Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get AMRX alerts

About Jason Daly

The proxy statement of Amneal Pharmaceuticals, Inc. reports total compensation of $2,860,442 for Jason Daly in fiscal 2025, including a base salary of $560,019. Disclosed compensation is on record for 4 fiscal years. Jason Daly has spoken on 1 earnings call across 1 company, most recently for Amneal Pharmaceuticals, Inc. on November 4, 2022. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.

Jason Daly on recent calls

“To date, the focus of those trials and resolutions has been on those who have engaged in direct promotion, where large-scale distribution, and pharmacy distribution of those products.”
General Counsel, Amneal Pharmaceuticals, Inc. Q3 FY2022 Earnings Call ·

Affiliation history

Company network

Leadership on record at Amneal Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Amneal Pharmaceuticals, Inc. (AMRX) $560,019 $2,860,442
2024 Amneal Pharmaceuticals, Inc. (AMRX) $502,731 $2,383,794
2023 Amneal Pharmaceuticals, Inc. (AMRX) $470,135 $1,349,396
2022 Amneal Pharmaceuticals, Inc. (AMRX) $401,538 $1,720,937

Recent activity